% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • doctorevensen doctorevensen Jun 24, 2012 2:55 PM Flag

    a very good point in the transcript

    There were several very good valid points mentioned in the discussion in the transcripts that I think will drive this stock to approval.
    1. The mention that they were required to solo this drug during the trials rather than combine it with another for increased weight loss. The goal was to use it as an adjunct with other meds that work in synergy with Lorqess to have an improved weight Lor-phen.
    2. The other point was that there is receptor variation among the patient populations, therefore there will be a variance of responses. Just like with hypertension, sometimes it takes the additional meds to until a combo is found that works for the patient. Lorqess will be a much needed, and the newest gun in the armory, which has dwindled down to only a few meds.......

    These points will drive the FDA past the somewhat low average weight loss seen. Especially with the current heat on the government to fight the current number one killer in America...OBESITY!!!!!! There is a political agenda in play......

    SortNewest  |  Oldest  |  Most Replied Expand all replies
4.48-0.04(-0.88%)Jul 7 4:00 PMEDT